Approach to Dyspepsia | Harrison based Session

THE WHITE ARMY2 minutes read

Dyspepsia, primarily categorized into functional dyspepsia and peptic ulcer disease, presents various symptoms that necessitate thorough evaluation and specific treatment approaches based on patient history and underlying causes. Diagnosis and management involve ruling out serious conditions with tools like endoscopy and H. pylori testing, while treatment varies from proton pump inhibitors to prokinetics depending on the syndrome identified.

Insights

  • Dyspepsia, commonly known as indigestion, is characterized by a range of symptoms related to difficult digestion, including early fullness and burning sensations in the upper abdomen, and is classified under the Rome IV criteria, which helps differentiate its various manifestations and underlying causes.
  • Functional dyspepsia makes up about 70% of dyspepsia cases, where no specific physical cause is identified, while peptic ulcer disease is the most frequent secondary cause; understanding this distinction is critical for proper diagnosis and treatment.
  • The diagnostic process for dyspepsia emphasizes the importance of ruling out alarm symptoms—such as unexplained weight loss or persistent vomiting—especially in individuals over 60, who may require an upper gastrointestinal endoscopy to check for serious conditions like cancer or ulcers.
  • Treatment approaches vary based on the type of dyspepsia: postprandial distress syndrome may be treated with prokinetics, while epigastric pain syndrome typically requires proton pump inhibitors; follow-up testing is essential after H. pylori treatment to confirm eradication and assess for any complications.

Get key ideas from YouTube videos. It’s free

Recent questions

  • What is functional dyspepsia?

    Functional dyspepsia is a common gastrointestinal disorder characterized by symptoms of discomfort or pain in the upper abdomen, often without any identifiable organic cause. It is diagnosed when patients experience symptoms such as early satiety, postprandial fullness, or epigastric pain for more than three months, with the onset occurring at least six months prior. This condition accounts for approximately 70% of dyspepsia cases and is categorized into two main syndromes: postprandial distress syndrome, which involves feelings of fullness and early satiety, and epigastric pain syndrome, which is marked by burning sensations and pain in the upper abdomen. Diagnosis typically involves ruling out other potential causes through endoscopy and ensuring that all tests return normal results. Treatment options may include dietary changes, medications like proton pump inhibitors, or prokinetics, depending on the specific symptoms presented.

  • How is H. pylori infection diagnosed?

    H. pylori infection can be diagnosed using several non-invasive tests, including the urea breath test (UBT) and stool antigen tests. These methods are sensitive and specific for detecting the presence of H. pylori bacteria in the gastrointestinal tract. The urea breath test involves the patient ingesting a substance that H. pylori can metabolize, and then measuring the resulting carbon dioxide in the breath. Stool antigen tests detect H. pylori proteins in a stool sample. If these tests return positive, treatment typically involves a combination of a proton pump inhibitor and antibiotics to eradicate the infection. In cases where endoscopy is performed, biopsies can also be taken to conduct a rapid urease test, which provides immediate results regarding the presence of H. pylori. It is essential to confirm eradication of the bacteria after treatment through follow-up testing.

  • What are alarm symptoms in dyspepsia?

    Alarm symptoms in dyspepsia are specific clinical indicators that suggest the presence of a more serious underlying condition, such as gastric cancer or peptic ulcer disease. These symptoms include unintentional weight loss, difficulty swallowing (dysphagia), painful swallowing (odynophagia), unexplained iron deficiency anemia, persistent vomiting, a palpable mass or lymphadenopathy, and a family history of upper gastric cancer. The presence of any of these alarm symptoms warrants a thorough evaluation, often including an upper gastrointestinal (UGI) endoscopy, especially in patients over the age of 40. Identifying alarm symptoms is crucial for timely diagnosis and treatment, as they may indicate conditions that require immediate medical intervention.

  • What is the treatment for peptic ulcer disease?

    The treatment for peptic ulcer disease (PUD) primarily focuses on eradicating H. pylori infection, if present, and managing symptoms. The first-line therapy typically involves a combination of a proton pump inhibitor (PPI), clarithromycin, and either amoxicillin or metronidazole, known as clarithromycin triple therapy, administered for 14 days. In cases where there is resistance to clarithromycin or metronidazole, bismuth quadruple therapy may be used as an effective alternative. This regimen also lasts for 14 days and is particularly common in regions with higher resistance rates. After treatment, follow-up testing, such as a urea breath test or stool antigen test, is recommended to confirm the eradication of H. pylori. For patients with gastric ulcers, a biopsy may be necessary to rule out malignancy, and repeat endoscopy may be required to ensure healing and monitor for any complications.

  • What distinguishes dyspepsia from GERD?

    Dyspepsia and gastroesophageal reflux disease (GERD) are both gastrointestinal conditions, but they are characterized by different symptoms and underlying issues. Dyspepsia, often referred to as indigestion, involves a range of symptoms related to discomfort in the upper abdomen, such as early satiety, postprandial fullness, and epigastric pain or burning. In contrast, GERD is primarily characterized by heartburn, which is a burning sensation that radiates retrosternally, and regurgitation, where gastric contents are involuntarily expelled into the esophagus. The presence of heartburn as a predominant symptom typically suggests a diagnosis of GERD rather than dyspepsia. It is important for healthcare providers to differentiate between these conditions, as the treatment approaches may vary significantly, with GERD often requiring medications like PPIs specifically aimed at reducing acid reflux.

Related videos

Summary

00:00

Understanding Dyspepsia and Its Symptoms

  • Dyspepsia, often referred to as indigestion, is defined as a symptom complex related to difficulty in digestion, with its etymology indicating "bad digestion" from the Greek terms "dys" (bad) and "pepsia" (digestion).
  • The current understanding of dyspepsia is based on the Rome IV criteria, which categorize it as symptoms arising from pathology in the gastroduodenal region, including early satiety, postprandial fullness, epigastric burning, and epigastric pain.
  • Functional dyspepsia accounts for approximately 70% of cases, where no specific pathology is identified through investigations, while peptic ulcer disease is the most common secondary cause, making up the remaining 30%.
  • Symptoms of dyspepsia can be classified into two syndromes: postprandial distress syndrome (characterized by early satiety and postprandial fullness) and epigastric pain syndrome (characterized by epigastric burning and pain).
  • For a diagnosis of functional dyspepsia, symptoms must persist for more than three months, with onset occurring at least six months prior, and all investigations, including endoscopy and ultrasound, must return normal results.
  • Other potential secondary causes of dyspepsia include peptic ulcer disease, NSAID gastropathy, gastric cancer, and pancreatic or biliary disorders, with the latter being easier to diagnose due to associated symptoms like jaundice and enzyme abnormalities.
  • Dyspeptic symptoms are distinct from heartburn, regurgitation, and acid reflux; heartburn is characterized by a burning sensation that radiates retrosternally, while regurgitation involves involuntary expulsion of gastric contents.
  • The presence of heartburn as a predominant symptom suggests a diagnosis of gastroesophageal reflux disease (GERD) rather than dyspepsia, as dyspepsia is specifically related to gastroduodenal issues.
  • Gastritis, often confused with dyspepsia, is a histological term and should not be used interchangeably; while gastritis can cause dyspeptic symptoms, it is not a clinical syndrome itself.
  • Treatment for heartburn typically involves proton pump inhibitors (PPIs), which are more effective for heartburn than for regurgitation, highlighting the importance of distinguishing between these symptoms for appropriate management.

14:39

Diagnosing Esophageal and Dyspeptic Disorders

  • Severe ulcerative esophagitis or pill-induced esophagitis can lead to painful swallowing, regurgitation, and symptoms indicating esophageal issues, necessitating careful patient history to differentiate between esophageal and gastroduodenal problems.
  • Water brash, characterized by excessive salivation due to esophageal injury, is a symptom that should be evaluated alongside heartburn and dyspeptic symptoms to determine the primary source of discomfort.
  • It is crucial to conduct a thorough history and endoscopic examination to identify whether symptoms are primarily esophageal or related to gastric conditions, as misdiagnosis can lead to inappropriate treatment.
  • Functional dyspepsia accounts for 70% of dyspepsia cases, which can be categorized into postprandial distress syndrome and epigastric pain syndrome, while peptic ulcer disease is a significant secondary cause that must be ruled out.
  • The diagnostic algorithm for dyspepsia should focus on identifying peptic ulcer disease first, as early detection is vital for effective treatment and to prevent complications.
  • In cases of dyspepsia, the presence of H. pylori is a primary concern, and it can be detected using non-endoscopic tests such as the urea breath test (UBT) or stool antigen tests, which are both sensitive and specific.
  • For patients over 60 years old or those exhibiting alarm symptoms (e.g., weight loss, lymphadenopathy, persistent symptoms), an upper gastrointestinal (UGI) endoscopy is recommended to rule out complications like cancer or ulcers.
  • During UGI endoscopy, a biopsy may be taken to perform a rapid urease test, which helps confirm the presence of H. pylori and assess for any malignancies or complications.
  • After confirming H. pylori infection, treatment typically involves a proton pump inhibitor (PPI) for a minimum of two weeks, followed by an additional two weeks of PPI therapy to ensure eradication, which can be confirmed through subsequent UBT or stool antigen tests.
  • Current guidelines suggest that for new-onset dyspepsia, particularly in patients over 60, a thorough evaluation is necessary to exclude serious underlying conditions, with some sources recommending a lower age threshold of 40 for similar assessments.

27:25

Dyspepsia Evaluation and Management Guidelines

  • Dyspepsia evaluation begins with ruling out alarm symptoms, such as unintentional weight loss, dysphagia, or a family history of upper gastric cancer, especially in patients over 40 years old, who should be referred to a gastroenterologist for an upper gastrointestinal (UGI) endoscopy.
  • For patients without alarm symptoms, non-invasive testing for H. pylori is recommended, using either a urea breath test or stool antigen test; if positive, initiate therapy, and if negative, trial treatment with proton pump inhibitors (PPIs) or H2 blockers before considering gastroenterology referral.
  • Alarm symptoms include unintentional weight loss, dysphagia, odynophagia, unexplained iron deficiency anemia, persistent vomiting, palpable mass or lymphadenopathy, and a family history of upper gastric cancer.
  • In patients over 60 years old or with alarm features, perform UGI endoscopy to obtain biopsies and conduct a rapid urease test; if positive, treat accordingly, and if negative, label as functional dyspepsia.
  • Functional dyspepsia is characterized by postprandial fullness or early satiety occurring more than three days a week for over six months, or epigastric pain or burning more than once a week for the same duration.
  • Treatment for functional dyspepsia varies: for postprandial distress syndrome, prokinetics are the first-line therapy, while for epigastric pain syndrome, PPIs are recommended.
  • In cases of uninvestigated dyspepsia, 70% of endoscopies yield normal results; however, if abnormalities are found, such as ulcers or erosive esophagitis, appropriate treatment should be initiated based on findings.
  • For patients with gastric ulcers, a biopsy is essential to rule out malignancy, while duodenal ulcers typically do not require biopsy unless malignancy is suspected.
  • The Sydney protocol for H. pylori testing involves taking five biopsies from various stomach regions, especially if atrophic gastritis is present, as H. pylori may migrate to the proximal stomach in such cases.
  • Prior to conducting a rapid urease test, patients must stop PPIs for four weeks, H2 blockers for one week, and antibiotics for four weeks to ensure accurate results, as a minimum of 10^5 bacteria is required for a positive test.

40:12

H Pylori Diagnosis and Treatment Overview

  • A proximal biopsy or a urea breath test is necessary if the rapid test for H. pylori is negative; a 24-hour wait is required to confirm a negative result, and testing should not be conducted in cold environments to avoid delayed positivity.
  • In cases of profuse gastrointestinal bleeding or atrophy, bacteria may not survive, making biopsy during endoscopy impossible; alternative testing or delayed biopsy is required.
  • Peptic ulcer disease (PUD) is the second most common cause of dyspepsia, primarily due to H. pylori, with pepsin being the proteolytic agent at acidic pH, rather than the acid itself.
  • Risk factors for PUD include advanced age, COPD, chronic renal failure, nephrolithiasis, alpha-1 antitrypsin deficiency, hyperparathyroidism, coronary artery disease, polycythemia, chronic pancreatitis, former alcohol use, obesity, being African American, and having three or more doctor visits in one year.
  • Functional dyspepsia is diagnosed when no specific cause is found after endoscopy and biopsy; it is categorized into postprandial distress syndrome (characterized by fullness and early satiety) and epigastric pain syndrome (characterized by pain and burning).
  • Treatment for postprandial distress syndrome may include prokinetics and PPIs, while epigastric pain syndrome typically requires PPIs, with the option to add prokinetics if necessary.
  • If symptoms persist despite treatment, further options include fundic relaxers or 5-HT1A agonists like risperidone or mirtazapine, and if symptoms remain unresolved, a gastric emptying study is warranted to check for gastroparesis.
  • The first-line treatment for H. pylori is the FDA-approved clarithromycin triple therapy, which consists of a PPI, clarithromycin, and either amoxicillin or metronidazole, administered for 14 days; however, resistance issues may necessitate alternative therapies.
  • Bismuth quadruple therapy is an effective alternative in cases of clarithromycin or metronidazole resistance, also lasting 14 days, and is often used in India due to higher resistance rates.
  • After treatment for H. pylori, a follow-up urea breath test or stool antigen test is recommended to confirm eradication, and repeat endoscopy is necessary for benign gastric ulcers to ensure healing and rule out malignancy.

52:59

Upper GI Endoscopy Guidelines for Dyspepsia

  • For patients over 60 years old or those with persistent alarm symptoms after treatment, an upper gastrointestinal (UGI) endoscopy is recommended to rule out complications such as H. pylori infection, esophageal issues, or cancer. Non-invasive tests like the urea breath test, stool antigen test, or biopsy can be used for younger patients or those without alarm features, but if H. pylori is confirmed, treatment should follow. If no issues are found, the diagnosis is functional dyspepsia, which can be categorized into postprandial distress syndrome or epigastric pain syndrome, treated with prokinetics or proton pump inhibitors (PPIs) combined with selective serotonin reuptake inhibitors (SSRIs).
  • The role of UGI endoscopy is not to confirm H. pylori but to identify any complications or other gastrointestinal tract issues that may cause dyspepsia. Various methods for H. pylori testing, including rapid urease tests, urea breath tests, and stool antigen tests, are all valid. If bleeding occurs during UGI endoscopy, alternative testing methods can still be employed. Future sessions will cover other gastrointestinal symptoms, particularly those related to the esophagus and lower GI tract.
Channel avatarChannel avatarChannel avatarChannel avatarChannel avatar

Try it yourself — It’s free.